TAFINLAR for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 23 adverse event reports in the FDA FAERS database where TAFINLAR was used for Malignant melanoma.
Most Reported Side Effects for TAFINLAR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pyrexia | 29 | 24.0% | 1 | 11 |
| Death | 14 | 11.6% | 14 | 4 |
| Rash | 11 | 9.1% | 0 | 2 |
| Nausea | 9 | 7.4% | 0 | 4 |
| Vomiting | 9 | 7.4% | 0 | 5 |
| Chills | 8 | 6.6% | 1 | 2 |
| Diarrhoea | 7 | 5.8% | 0 | 2 |
| Disease progression | 7 | 5.8% | 4 | 0 |
| Headache | 6 | 5.0% | 0 | 1 |
| Arthralgia | 5 | 4.1% | 0 | 0 |
| Decreased appetite | 5 | 4.1% | 1 | 1 |
| Dehydration | 5 | 4.1% | 0 | 4 |
| Myalgia | 5 | 4.1% | 0 | 2 |
| Pain in extremity | 5 | 4.1% | 0 | 2 |
Other Indications for TAFINLAR
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
DABRAFENIB (5,277)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
ENCORAFENIB (2,591)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
COBIMETINIB (1,324)